Advances in Clinical and Experimental Medicine
2014, vol. 23, nr 4, July-August, p. 599–603
Publication type: original article
Language: English
Validation of Self Report Version of the Leeds Assessment of Neuropathic Symptoms and Signs Score for Identification of Neuropathic Pain in Patients from Northern Turkey
1 Department of Neurology, Kirikkale University, Faculty of Medicine, Kirikkale, Turkey
2 Department Neurology, Ondokuz Mayis University, Faculty of Medicine, Samsun, Turkey
3 Neurology Clinic, Carsamba Public Hospital, Samsun, Turkey
Abstract
Background. Diagnosis and treatment of neuropathic pain is an important clinical problem.
Objectives. A self report version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score provides identification of neuropathic pain without the help and need of a clinician. We targeted validation of the S-LANSS score in the nothern Turkish population in this study.
Material and Methods. For the linguistic validation of S-LANSS, translation and back-translation method was used to adapt S-LANSS into Turkish and a cognitive-debriefing test was performed. A total of 148 patients were enrolled in the present study. S-LANSS, The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Visual Annalogue Score (VAS) and Neuropathic Pain Questionnaire (NPQ) were performed twice for every patient. The patients were examined and diagnosed as having nociceptive or neuropathic pain by neurologists, who were blind for S-LANSS, LANSS and NPQ scores of the patients.
Results. Results of the McNemar test indicated that S-LANSS scores were reliable when the first and the second scores were compared. The sensitivity and specificity of the scale were found to be 98% and 97% respectively.
Results. Conclusions.
Conclusion. We believe that using S-LANSS scores for the diagnosis of neuropathic pain may help our colleagues as a tool for a quicker differential diagnosis of pain in daily practice.
Key words
S-LANSS, neuropathic pain, validation.
References (11)
- International Association for the Study of Pain. Classification of chronic pain. Pain 1986, Suppl 3, 1–225.
- Merskey H, Bogduk N, eds. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of PainTerms, 2nd ed. Seattle, WA, IASP Press, 1994.
- Bennett G: Neuropathic pain: a crisis of definition? Anesth Analg 2003, 97, 619–620
- Krause SJ, Backonja MM: Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19, 306–314.
- Martinez-Lavin M, Lopez S, Medina M, Nava A: Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 2003, 32, 407–411.
- Potter J, Higginson IJ, Scadding JW, Quigley C: Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med 2003, 96, 379–383.
- Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 1997, 48, 332–338.
- Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Biureau F: Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004, 108, 248–257.
- Yücel A, Senocak M, Orhan EK, Cimen A, Ertaş M: Results of the Leeds Assessment of neuropathic symptoms and signs pain scale in Turkey: A validation study. J Pain 2004, 5, 427–432.
- Bennett MI, Smith BH, Torrance N, Potter J: The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J Pain 2005, 6, 149–158.
- Koc R, Erdemoglu AK: Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire. Pain Med 2010, 11, 1107–1114.